Literature DB >> 11229451

Strategies for the treatment of antidepressant-related sexual dysfunction.

J Zajecka1.   

Abstract

Sexual dysfunction and dissatisfaction are common symptoms associated with depression. Optimal antidepressant treatment should result in remission of the symptoms of the underlying illness and minimize the potential for short- and long-term adverse effects, including sexual dysfunction. Sexual dysfunction and dissatisfaction are frequently persistent or worsen with the use of some antidepressant medications; this sexual dysfunction and dissatisfaction can have negative impact on adherence to treatment, quality of life, and the possibility of relapse. Successful management of sexual complaints during antidepressant treatment should begin with a systematic approach to determine the type of sexual dysfunction, potential contributing factors, and finally management strategies that should be tailored to the individual patient. The basic physiologic mechanisms of the normal sexual phases of libido, arousal, and orgasm and how these mechanisms may be interrupted by some antidepressants provide a framework for the clinician to utilize in order to minimize sexual complaints when initiating and continuing antidepressant treatment. This article provides guidelines, based upon this type of model, for the assessment, management, and prevention of sexual side effects associated with antidepressant treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11229451

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  8 in total

Review 1.  [Sex- and gender-aspects in regard to clinical practice recommendations for pre-diabetes and diabetes].

Authors:  Alexandra Kautzky-Willer; Heidemarie Abrahamian; Raimund Weitgasser; Peter Fasching; Fritz Hoppichler; Monika Lechleitner
Journal:  Wien Klin Wochenschr       Date:  2016-04       Impact factor: 1.704

2.  [Adverse side-effect on sexual function caused by psychotropic drugs and psychotropic substances].

Authors:  S Cohen; K U Kühn; B Sträter; N Scherbaum; W Weig
Journal:  Nervenarzt       Date:  2010-09       Impact factor: 1.214

3.  Effects of adjunctive aripiprazole on sexual functioning in patients with major depressive disorder and an inadequate response to standard antidepressant monotherapy: a post hoc analysis of 3 randomized, double-blind, placebo-controlled studies.

Authors:  Maurizio Fava; Christina M Dording; Ross A Baker; Raymond Mankoski; Quynh-Van Tran; Robert A Forbes; James M Eudicone; Randall Owen; Robert M Berman
Journal:  Prim Care Companion CNS Disord       Date:  2011

4.  A novel approach for predicting antidepressant-induced sexual dysfunction in rats.

Authors:  Stacey J Sukoff Rizzo; Lee E Schechter; Sharon Rosenzweig-Lipson
Journal:  Psychopharmacology (Berl)       Date:  2007-09-16       Impact factor: 4.530

5.  Antidepressant-associated sexual dysfunction: impact, effects, and treatment.

Authors:  Agnes Higgins; Michael Nash; Aileen M Lynch
Journal:  Drug Healthc Patient Saf       Date:  2010-09-09

6.  A genome-wide association study of female sexual dysfunction.

Authors:  Andrea Burri; Pirro Hysi; Alex Clop; Qazi Rahman; Tim D Spector
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

7.  Treatment of multiple distressing spontaneous orgasms with citalopram and their re-emergence following discontinuation of prolonged use of citalopram in an adult female survivor of child sexual abuse.

Authors:  Adarsh Vohra
Journal:  Indian J Psychiatry       Date:  2012-10       Impact factor: 1.759

Review 8.  Toward achieving optimal response: understanding and managing antidepressant side effects.

Authors:  Karen Kelly; Michael Posternak; Jonathan E Alpert
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.